Cafepharma Today

January 30 2025 - Novo Nordisk commences fresh trials for CagriSema
Novo Nordisk commences fresh trials for CagriSema
Express Scripts becomes latest PBM to follow in Mark Cuban's footsteps
With efficacy assured, Merck halts another trial of blockbuster-to-be Winrevair
Sanofi plans €5 billion buyback, sees higher profit growth
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Four Value Priced Stocks: Sysco, Eli Lilly, PepsiCo and Johnson & Johnson
Seeking Alpha
Tuesday, October 7, 2008 - 10:06am
tags:
Cypress Bioscience, Worth Watching for Fibromyalgia Drug
Cafepharma Detailpiece
Tuesday, October 7, 2008 - 10:05am
tags:
NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies
Yahoo
Tuesday, October 7, 2008 - 9:04am
tags:
Biotech ETFs Hold Their Own During Crisis
Seeking Alpha
Tuesday, October 7, 2008 - 8:47am
tags:
Drugmakers Urged By UK To Lower Prices
Pharmalot
Tuesday, October 7, 2008 - 8:47am
tags:
Shire colitis drug 'demonstrates steady medicine release'
Hays Pharma
Tuesday, October 7, 2008 - 8:46am
tags:
Salix Pharmaceuticals (SLXP) Presents Data on Mesalamine Granules Once-Daily Maintained Remission at ACG 2008
Street Insider
Tuesday, October 7, 2008 - 8:40am
tags:
Eli Lilly resolves investigation over Zyprexa with 32 states
Marketwatch
Tuesday, October 7, 2008 - 8:39am
tags:
AtheroGenics Files for Chapter 11 Bankruptcy
Yahoo
Tuesday, October 7, 2008 - 8:22am
tags:
Alpharma agrees to share confidential financials with suitor King Pharmaceuticals
Yahoo/AP
Tuesday, October 7, 2008 - 8:21am
tags:
Medicine for a sector
FT.com
Tuesday, October 7, 2008 - 7:53am
tags:
Medtronic CEO Hawkins Says Stent Patent Win Worth $114 Million
Bloomberg
Tuesday, October 7, 2008 - 7:52am
tags:
UBS Helps Lilly Buy ImClone, Says Price Too High
Bloomberg
Tuesday, October 7, 2008 - 7:50am
tags:
Genentech and Biogen say Rituxan slowed leukemia progress in late stage clinical trial
Yahoo/AP
Tuesday, October 7, 2008 - 7:49am
tags:
Four Thoughts on the Imclone/Lilly Deal
Seeking Alpha
Tuesday, October 7, 2008 - 7:46am
tags:
A Biotech Bonanza for ImClone and Dendreon
Seeking Alpha
Tuesday, October 7, 2008 - 7:45am
tags:
Synavive data sends CombinatoRx to all-time lows
Yahoo/AP
Tuesday, October 7, 2008 - 7:44am
tags:
Fitch may downgrade Eli Lilly's 'AA' on ImClone buy
Marketwatch
Tuesday, October 7, 2008 - 7:43am
tags:
Dendreon Misses, Moves Up
Forbes
Monday, October 6, 2008 - 10:58am
tags:
September FDA news in review
Fierce Pharma
Monday, October 6, 2008 - 10:57am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information